Bioqual Net Worth 2010-2025 | BIOQ

Interactive chart of historical net worth (market cap) for Bioqual (BIOQ) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Bioqual net worth as of July 15, 2025 is $0.04B.
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.039B $0.059B
BIOQUAL, Inc., formerly Diagnon Corporation, develops, produces and sells diagnostic test kits incorporating monoclonal antibodies to diagnose certain anemias, infections, and parasitic diseases.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $18.578B 18.31
Encompass Health (EHC) United States $10.813B 22.92
DaVita (DVA) United States $10.610B 14.92
Elanco Animal Health (ELAN) United States $7.256B 15.54
Chemed (CHE) United States $6.638B 20.86
Option Care Health (OPCH) United States $5.034B 22.44
RadNet (RDNT) United States $4.161B 264.10
Amedisys (AMED) United States $3.200B 21.52
Addus HomeCare (ADUS) United States $2.013B 22.11
LifeStance Health (LFST) United States $1.711B 0.00
Astrana Health (ASTH) United States $1.373B 34.01
U.S Physical Therapy (USPH) United States $1.111B 28.69
Pennant (PNTG) United States $0.843B 30.96
Aveanna Healthcare Holdings (AVAH) United States $0.788B 44.89
Atai Life Sciences (ATAI) Germany $0.531B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.039B 0.00
Ontrak (OTRK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00